ghk-cu clinical trial 2025 100mg | Copper Peptide for Research GHK-Cu / KPV · Disguised

This blend combines Tesamorelin, a stabilized analogue of growth-hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth-hormone-secretagogue-receptor (GHS-R) peptide

In the longer run gives lighter, brighter skin tone to lighten and also helps decrease wrinkles and increase skin elasticity

Cagrilintide is a long-acting amylin analogue and amylin receptor agonist used in laboratory research to investigate amylin receptor signalling, satiety mechanisms, gastric emptying regulation, and metabolic pathway modulation in experimental models

CJC-1295 and Ipamorelin stimulate endogenous HGH release, while AOD-9604 targets fat directly without affecting IGF-1. This dual action can accelerate fat loss and body recomposition

Copper-Mediated Pathways: Research has explored its role as a copper-binding tripeptide in cellular signalling, antioxidant defence, and collagen-related biological models